Federation des caisses Desjardins du Quebec’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10
Closed -$1.52K 2166
2020
Q2
$1.52K Hold
10
﹤0.01% 1969
2020
Q1
$833 Hold
10
﹤0.01% 2079
2019
Q4
$1.69K Hold
10
﹤0.01% 2157
2019
Q3
$1.86K Hold
10
﹤0.01% 2095
2019
Q2
$2.29K Hold
10
﹤0.01% 2094
2019
Q1
$2.1K Hold
10
﹤0.01% 1921
2018
Q4
$1.15K Hold
10
﹤0.01% 1949
2018
Q3
$2.29K Hold
10
﹤0.01% 1982
2018
Q2
$2.23K Hold
10
﹤0.01% 2005
2018
Q1
$2.29K Hold
10
﹤0.01% 1985
2017
Q4
$2.62K Hold
10
﹤0.01% 1967
2017
Q3
$2.25K Hold
10
﹤0.01% 1931
2017
Q2
$2.73K Hold
10
﹤0.01% 1978
2017
Q1
$2.42K Buy
+10
New +$2.29K ﹤0.01% 1642

Other funds holding AXDX

Federation des caisses Desjardins du Quebec's AXDX Position: Q3 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Accelerate Diagnostics (AXDX) in Q3 2020, closing a stake of 10 shares — an estimated $1.52K sold.

Federation des caisses Desjardins du Quebec first reported a position in AXDX in Q1 2017 and held it in 14 quarters. The position peaked at $2.73K in Q2 2017. 112 funds tracked by Wall St. Rank hold AXDX as of Q3 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Accelerate Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 10 Accelerate Diagnostics shares in Q3 2020, an estimated $1.52K.
  • Federation des caisses Desjardins du Quebec first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 14 quarters.
  • Federation des caisses Desjardins du Quebec's Accelerate Diagnostics position peaked at $2.73K in Q2 2017.
  • 112 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2020, filed 30 Aug 2024.